Naegis Pharmaceuticals
Vancouver
About Naegis Pharmaceuticals
Naegis Pharmaceuticals Inc. is a Canadian biopharmaceutical company developing novel, small molecules for the treatment of serious inflammatory diseases.Chronic inflammatory disease represents an enormous societal and economic burden, particularly in an aging population, impacting both quality and quantity of life. Naegis Pharmaceuticals Inc. is driven to discover new therapies that target underlying chronic inflammatory processes in disease. The Naegis research team seeks to design new drugs that offer safer and more effective treatment options for patients, focusing first on serious eye conditions that result in damage to the back of the eye, with a program directed towards blocking the synthesis of pro-inflammatory mediators in disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $350.8K
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: naegispharma.com
- Phone: 604-235-1682
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/naegis-pharmaceuticals-122550 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.